loader image
Friday, November 28, 2025
74 F
McAllen
- Advertisement -

How Does Diabetes Affect Wound Healing?

Health & Lifestyle
569

Translate to Spanish or other 102 languages!

A person who manages their diabetes well can improve the rate at which wounds heal and reduce the likelihood of a severe infection. Image for illustration purposes
A person who manages their diabetes well can improve the rate at which wounds heal and reduce the likelihood of a severe infection. Image for illustration purposes

Medical News Today

- Advertisement -

In people with diabetes, wounds can take longer to heal. These wounds often appear on the feet and legs. This slow healing can increase the risk of developing infections and other complications.

A person who manages their diabetes well can improve the rate at which wounds heal and reduce the likelihood of a severe infection.

Follow the link below to read the full story on Medical News Today:

- Advertisement -

https://www.medicalnewstoday.com/articles/320739

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Take Precautions When Venturing Outside
Next article
Instructor Gives Hope to Aspiring Health Care Professionals

More Articles

STHS Behavioral Hosting Webinar on Seasonal Depression, Dec. 4

Mega Doctor News It’s common for individuals to experience an emotional downturn during the winter...

AMA Adopts New Public Health Policies to Improve Health of the Nation

The American Medical Association (AMA) gathered physician and medical student leaders from all corners of medicine at its Interim Meeting of the House of Delegates to shape guiding policies on emerging health care topics.

Study Finds Best Strategy for Reducing Belly Fat

Over the last few years, research has shown that having excessive visceral fat — the fat surrounding the abdominal area that protects internal organs — can be detrimental to a person’s health.

FDA Approves Gene Therapy for Treatment of Spinal Muscular Atrophy

The U.S. Food and Drug Administration approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in adult and pediatric patients 2 years of age and older with confirmed mutation in the survival motor neuron 1 (SMN1) gene. Itvisma is an adeno-associated virus (AAV) vector-based gene therapy.
- Advertisement -

We feature articles about leading professionals in the medical and healthcare industry in the South Texas area. We are your connection to the medical community!

Pick up a copy of our publication on more than 800 locations Valley-wide.

Contact Us

Office (956) 928-1255

Sales (956) 451-4585

info@tbbmega.com

sales@tbbmega.com

Subscribe

© Mega Doctor News 2025

×